![](/img/cover-not-exists.png)
Design and Rationale for Randomized, Doubleblind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Patients With Diabetic Nephropathy (DN)
Sabounjian, LuAnn, Shipley, James, Braman, Virginia, Harnett, Mark, Wu, Lijun, Turnquist, David, Graham, PhilipVolume:
19
Year:
2012
Language:
english
DOI:
10.1053/j.ackd.2012.02.007
File:
PDF, 50 KB
english, 2012